An investigational site saying that they are shooting for 2021 not decrease the time it takes for clinical trials to occur. Do you know when CAB had its investigational trial? Years ago. The pharmacokinetics was presented in abstract form in 2013. CAB’s Phase III trial started recruiting in 2016. The clinical trial process takes YEARS and Gilead has literally only presented the investigational study which is the first phase of clinical trials. They still have to do Phase 2 and 3 trials. At some point someone rational has to realize that it is impossible for Gilead to launch an injectable anytime soon. It just doesn’t work that way unless you’re a breakthrough drug and HIV is not in that space anymore (unless someone has a cure).
Yes, 2021. Doubt they will be able to do it sooner. They are hoping for end of 2020, but that may just be another instance of clueless wishful thinking that runs epidemic in the company. The same kind that gave us blockbuster projections for Dovato and the whole concept of 2DR. The same kind that told us two buttock injections would be "paradigm changing" in a space where one pill once a day was the standard.
Let's get to the bottom line. Layoffs are inevitable. We never never never should have hired an additional salesforce! Never never never! Leadership was warned by existing salespeople that this was a bad idea. Now we suffer with the anxiety of possibly being laid off. You are going to have existing really good ViiV reps who have done nothing wrong lose their jobs. All because leadership had their head up their a$$! I'm stressed, my family is stressed and work is suffering because of this. Message to Baxter & Fink...just do it already! Announce the layoff and give the criteria you will use. This 5-6 rep per territory is a colossal mess! You are permanently ruining customer relationships and access. Please, stop the damage you have created. Just announce the layoff! Ughhhhhh! So frustrating!!!
Good study design and decision making can take years off clincial trial programmes so it's not impossible. Teams have to take smart risks to get there and theres an expectation to this for the newer drug programmes now. patient safety is always paramount though regardless...
How in the world are you coming up with this timeline when they haven’t even done the recruiting for their phase 2 study yet??? Are you basing this on real experience with timelines for clinical trials or are you pulling this out of the air?
started...not completed. I’m saying they aren’t done with the recruiting for the study and they have just started 3 months ago. Recruiting is the most time consuming part of a clinical trial. I am not quite sure why you think the clinical trial process is swift. Breakthrough designation is not the same as fast track. Gilead has literally just started the most time consuming part of the clinical trial process that can’t be skipped. Look at the data for how long it takes to progress from Phase 1 investigational to Phase 2 to Phase 3. They’ve only completed Phase 1.
either way it looks like we can all agree that it won’t be here in 2021 or early 2022. Anything after that is speculation on our parts.
Confirmed - layoffs in GSK HIV space spring/summer of 2020. 25-40% reduction by reps decision first (termination by agreement), followed by forced layoffs for those left identified by management. Be prepared.
LMAO! "confirmed". What a dusche! We all know a layoff is coming. However, you have no idea on what the criteria will be nor do you have a date. Stop spreading the hate my friend. Move on and move out.
The shot will have a market...2DR has a long way to go. Only time will tell if HCPs eventually change their thinking when it comes to 2DRs, unfortunately we don’t have the luxury of time and it is tough sledding out there.
